Neurocrine Biosciences (NBIX) Goodwill & Intangibles (2022 - 2026)

Neurocrine Biosciences (NBIX) has reported Goodwill & Intangibles for 5 consecutive years, with $2.7 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Goodwill & Intangibles rose 7229.57% year-over-year to $2.7 billion; the trailing twelve-month figure through Jun 2026 stood at $2.7 billion (up 7229.57% YoY), and the FY2025 full-year result was $10.8 million, down 74.41% from the prior year.
• Goodwill & Intangibles advanced to $2.7 billion in Q2 2026 per NBIX's latest filing, from $6.0 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $2.7 billion in Q2 2026 and bottomed at $6.0 million in Q1 2026.
• Historically, Goodwill & Intangibles has averaged $215.0 million across 5 years, with a median of $40.4 million in 2023.
• The widest YoY moves for Goodwill & Intangibles: up 7229.57% in 2026, down 83.52% in 2026.
• Over 5 years, Goodwill & Intangibles stood at $42.6 million in 2022, then dropped by 3.05% to $41.3 million in 2023, then advanced by 2.18% to $42.2 million in 2024, then slumped by 74.41% to $10.8 million in 2025, then surged by 25146.3% to $2.7 billion in 2026.
• According to Business Quant data, Goodwill & Intangibles over the past three periods registered $2.7 billion, $6.0 million, and $10.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.